Core Viewpoint - Fuyao Glass has established its aluminum parts business as an independent business unit, showing significant results in its operations and profitability [1] Group 1: Business Performance - The aluminum parts business unit (BU) is expected to report an operating loss of €12.8 million in 2025, which is a reduction of €16.47 million compared to the previous year, where it received a low compensation of €22.49 million [1] - Domestic revenue from aluminum decorative parts reached RMB 1.335 billion, representing a year-on-year growth of 23%, with an operating profit margin of nearly 10% [1] Group 2: Strategic Focus - The company aims to leverage the synergistic effects between aluminum decorative parts and automotive glass to enhance the profitability of the aluminum parts business unit [1]

Group 1 - Goldman Sachs reported that CK Hutchison's (00001) 2025 performance met expectations, with a basic net profit of HKD 22.3 billion, a 7% year-on-year increase, excluding a one-time loss of HKD 10.5 billion from the merger of 3UK and Vodafone UK [1] - The group's EBITDA grew by 7% year-on-year in local currency, indicating stable performance across various business segments [1] - The company declared a final dividend of HKD 1.6, with an annual dividend of HKD 2.3, representing a 5% increase and a stable payout ratio of approximately 40% [1] Group 2 - Goldman Sachs raised its earnings per share forecast for CK Hutchison by 11% for this year, while maintaining the forecast for next year and introducing projections for 2028 [2] - For the fiscal year 2026, Goldman Sachs predicts a 16% year-on-year growth in core earnings to HKD 25.9 billion, driven by synergies from the UK telecom merger and the benefits from rising oil prices for Cenovus Energy [2] - Sensitivity analysis indicates that a USD 1 increase in oil prices could lead to an increase in CK Hutchison's earnings by approximately HKD 300 million or 1-2% [2]

Group 1 - The company has agreed to acquire 1,623 ordinary shares of China Gene, representing 16.23% of its issued share capital, for a total cash consideration of HKD 43 million [1] - China Gene's main subsidiary, Huaxin, focuses on the research, production, and sales of biopharmaceutical products, particularly in gynecology and gene cell therapy [1] - The acquisition is seen as a strategic investment that will allow the company to expand its market presence in the healthcare and biopharmaceutical sectors in China, which are expected to grow significantly [2][3] Group 2 - The board believes that the acquisition will create potential long-term value and enhance the company's revenue through collaboration in the distribution of China Gene's biopharmaceutical products [2] - China Gene plans to adopt a dividend policy, aiming to distribute at least one-third of its after-tax profits after necessary provisions, which is expected to provide positive financial returns for the company [3] - The company currently has no plans or intentions for further acquisitions of China Gene's shares in the foreseeable future [4]

Core Viewpoint - The company EPS Creation Technology (03860) has agreed to acquire 1,623 shares of China Gene, representing 16.23% of its issued share capital, for a total cash consideration of HKD 43 million, which will be recognized as an investment in an associate in the consolidated financial statements of the group [1] Group 1: Acquisition Details - The acquisition agreement is set to be completed on February 12, 2026, with the total cash consideration being HKD 43 million [1] - Following the completion, the investment in China Gene will be accounted for as an investment in an associate [1] Group 2: Business Synergy and Strategy - The acquisition aligns with the company's existing healthcare product trading, medical device leasing, and CRO services, providing an excellent opportunity to participate in the operations of China Gene, which is experiencing strong growth in the favorable Chinese healthcare and biopharmaceutical market [2] - The company can leverage its extensive sales network in healthcare product trading to assist in the distribution of China Gene's listed biopharmaceutical products, potentially increasing revenue [2] - The integration of the value chain in the healthcare and biopharmaceutical ecosystem is expected to create synergies between the company's HCP and CRO businesses [2] Group 3: Financial Expectations - China Gene plans to adopt a dividend policy, aiming to distribute at least one-third of its after-tax profits after necessary provisions for taxes, loan repayments, and working capital needs [3] - The board anticipates that the investment in China Gene will yield positive financial returns and provide good business opportunities for future development, given its past profitability and dividend policy [3] - The acquisition is viewed as a strategic investment that will enhance the company's market participation in the Chinese healthcare and biopharmaceutical sectors, contributing positively to overall financial performance and long-term growth [3] Group 4: Future Acquisition Plans - The company currently has no plans or intentions for further acquisitions of equity in China Gene in the foreseeable future [4]

Core Viewpoint - The company is committed to "large capacity refrigerators + commercial cold chain" and is accelerating its upstream and global market expansion while focusing on research and innovation for high-quality development [1] Business Overview - The company's main business includes the research, production, and sales of large capacity refrigerators (400L and above) and commercial display cabinets, establishing itself as a well-known ODM supplier in the home appliance industry [1] Subsidiary Developments - In 2024, the company will establish a new controlling subsidiary, Wuliang Intelligent, focusing on PCBA processing, electronic component support, and hardware/software design for controllers, covering various fields such as smart home appliances, industrial control, energy storage, charging piles, and automotive electronics [1] - In 2025, another controlling subsidiary, Shengbang Electric, will be added, primarily engaged in specialized components like refrigeration parts, piping parts, and metal structural components, with applications in home appliances and light commercial sectors [1] Strategic Goals - The company aims to leverage business synergy to achieve efficient upstream and downstream collaboration, enhancing its core competitiveness by 2026 [1] - The company plans to further expand into overseas markets and accelerate its globalization strategy through a combination of strengthening its main business, upstream collaboration, and international layout to continuously explore markets and enhance its competitive capabilities [1]

Financial Data and Key Metrics Changes - The reported fourth quarter earnings per share (EPS) was $0.49, a significant decrease from $4.36 in the fourth quarter of 2024, impacted by unfavorable mark-to-market timing differences and notable items related to pension plan settlements and integration costs [10][11] - Adjusted EPS for the fourth quarter was $1.99, down from $2.13 in the prior year, while adjusted segment earnings before interest and taxes (EBIT) rose to $756 million from $546 million year-over-year [11][14] - Net interest expense increased to $176 million compared to the previous year, reflecting the addition of Viterra [14] Business Line Data and Key Metrics Changes - In the soybean processing and refining segment, results improved due to higher processing and refining outcomes in Argentina and Brazil, despite lower results in North America [11] - The soft seed processing and refining segment saw higher results driven by better average processing margins and the addition of Viterra's assets [12] - Grain merchandising and milling segment results improved due to global wheat and barley performance, although lower results were noted in global corn and ocean freight [13] Market Data and Key Metrics Changes - The environment remains complex with geopolitical tensions and trade flow uncertainties affecting farmer and consumer behavior [9] - The company expects full year 2026 adjusted EPS in the range of $7.50-$8, reflecting limited forward visibility particularly regarding U.S. biofuel policy [9][18] Company Strategy and Development Direction - The company is focused on integrating Viterra to enhance operational efficiency and connectivity across its global platform, aiming to unlock synergies in origination, merchandising, processing, and distribution [5][6] - The strategic investment in large greenfield projects continues, navigating trade flows and geopolitical volatility while connecting farmers to market demand [8][20] - The company emphasizes continuous improvement and resilience, positioning itself to deliver value in various market environments [20][21] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the complexity of the current environment, with limited visibility on future conditions, particularly regarding biofuel policy [9][18] - The company remains optimistic about its capabilities to adapt and succeed, leveraging the integration of Viterra to enhance its market position [20][21] Other Important Information - The company generated over $1.7 billion in adjusted funds from operations, with approximately $1.25 billion of discretionary cash flow available after capital expenditures [14][15] - The adjusted return on invested capital (ROIC) was reported at 8.1%, with an adjusted leverage ratio of 1.9 times at the end of the fourth quarter [16] Q&A Session Summary Question: Impact of RVO on margins and guidance - Management indicated that current guidance does not factor in potential changes from the Renewable Volume Obligation (RVO), but improvements in U.S. curves suggest a positive outlook [24][25] Question: Earnings cadence for the year - The company anticipates a first half to second half earnings split of approximately 30/70, with a lighter first half compared to historical trends [27][28] Question: Clarification on guidance methodology - Management confirmed that the same approach to guidance based on forward curves was used, with adjustments for market conditions expected once the RVO is finalized [34][35] Question: Potential for crush margins to replicate past performance - Management acknowledged the potential for improved margins due to increased capacity and favorable biofuel policies, but refrained from making specific predictions [39][40] Question: Synergies from Viterra integration - The company expects to realize approximately $190 million in synergies in 2026, ahead of schedule, with a run rate of around $220 million by year-end [51][52] Question: EPS guidance and segment performance - Management provided a breakdown of expected EBIT contributions by segment, with soy processing and refining expected to account for about 50% of total EBIT [87][88]

Financial Data and Key Metrics Changes - The reported fourth quarter earnings per share (EPS) was $0.49, a significant decrease from $4.36 in the fourth quarter of 2024, impacted by unfavorable mark-to-market timing differences and notable items related to pension plan settlements and integration costs [8][9] - Adjusted EPS for the fourth quarter was $1.99, down from $2.13 in the prior year, while adjusted segment earnings before interest and taxes (EBIT) rose to $756 million from $546 million year-over-year [9][12] - Net interest expense increased to $176 million compared to the previous year, reflecting the addition of Viterra [12] Business Line Data and Key Metrics Changes - In the soybean processing and refining segment, results improved due to higher processing and refining outcomes in Argentina and Brazil, despite lower results in North America [9][10] - The soft seed processing and refining segment saw higher results driven by better processing margins and the addition of Viterra's assets [10] - Grain merchandising and milling segment results improved due to global wheat and barley performance, offset by lower results in corn and ocean freight [11] Market Data and Key Metrics Changes - The environment remains complex with geopolitical tensions and trade flow uncertainties affecting farmer and consumer behavior [7] - The company expects full year 2026 adjusted EPS in the range of $7.50-$8, reflecting limited forward visibility particularly regarding U.S. biofuel policy [7][16] Company Strategy and Development Direction - The completion of the Viterra combination is seen as a major milestone, enhancing connectivity and information flow across the organization, which is expected to unlock durable synergies over time [4][5] - The company is focused on navigating trade flows and geopolitical volatility while connecting farmers to end market demand across food, feed, and fuel [6] - Continuous improvement and portfolio optimization are emphasized as part of the company's transformation journey [18] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the complex operating environment with limited visibility, particularly regarding U.S. biofuel policy, but expresses confidence in the company's ability to deliver value [7][19] - The company is optimistic about the capabilities built through the Viterra integration, which is expected to enhance customer service and risk management [18][19] Other Important Information - The company generated over $1.7 billion of adjusted funds from operations, with approximately $1.25 billion of discretionary cash flow available after capital expenditures [12][13] - The adjusted leverage ratio was 1.9 times at the end of the fourth quarter, reflecting the impact of acquisition debt from Viterra [14] Q&A Session Summary Question: Impact of RVO on margins and guidance - Management indicated that the outlook does not assume any changes from the Renewable Volume Obligation (RVO) but noted improvements in U.S. curves driven by RVO expectations [21][23] Question: Earnings cadence for the year - The company expects a first half to second half earnings split of approximately 30/70, with a lighter first half compared to typical seasonality [26][27] Question: Guidance methodology - The company confirmed that it uses the same approach for guidance based on forward curves and market conditions, without making speculative adjustments [33][34] Question: Synergies from Viterra integration - Management expects to realize about $190 million in synergies in 2026, ahead of schedule, with a run rate of approximately $220 million by year-end [50][51] Question: Biofuel policy and market opportunities - Management expressed optimism about the potential for biofuel policy to drive demand, although no significant contributions are included in the current forecast [94][96]

Group 1 - The trading activity in the precious metals futures market is expected to have a certain impact on the company's performance [1] - The company is in the process of acquiring a stake in a securities firm, which requires approval from the China Securities Regulatory Commission and other relevant authorities [1] - If the acquisition is approved and completed successfully, both parties will effectively integrate their business resources and fully leverage synergies, although the company's operational direction will not undergo significant changes [1]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - In 2025, the company achieved a total revenue of 2.14 billion yuan, a year-on-year increase of 40%, and a net profit attributable to shareholders of 228 million yuan, up 119% year-on-year [1] - The company's net assets attributable to shareholders reached 2.8 billion yuan, an increase of 24% compared to the end of 2024 [1] - In Q4 2025, the company reported a total revenue of 745 million yuan, a decrease of 1.04% year-on-year, and a net profit attributable to shareholders of 112 million yuan, down 48% year-on-year [1] Revenue and Profit Forecast - The company is expected to generate total revenue of 2.15 billion yuan in 2025, with a projected growth rate of 40.39% for 2026 and 35.02% for 2027 [1] - The net profit attributable to shareholders is forecasted to be 264 million yuan in 2026 and 347 million yuan in 2027, with corresponding growth rates of 15.95% and 31.32% respectively [1] - The earnings per share (EPS) is projected to be 0.43 yuan in 2026 and 0.57 yuan in 2027, with a price-to-earnings (P/E) ratio of 285.39 and 217.32 respectively [1] Business Performance - The software segment saw a revenue increase of 27.5% to 1.5 billion yuan, driven by a significant rise in advertising and user acquisition costs [6] - The brokerage segment, particularly through Mai Gao Securities, reported a net income from brokerage fees of 487 million yuan, a 110% increase year-on-year [6] - The company has terminated its plan to issue A-shares to specific investors and instead opted to issue subordinated bonds to supplement liquidity, raising a total of 480 million yuan [6]

Core Insights - The company achieved a total revenue of 2.1 billion with a year-on-year increase of 40% and a net profit attributable to shareholders of 228 million, up 119% [1] - In Q4 2025, the company reported a total revenue of 745 million, a slight decrease of 1.04% year-on-year, and a net profit of 112 million, down 48% [1] Software Segment - The market remains active with steady growth in performance; the average daily trading volume in A-shares increased by 64% to 17.3 trillion in 2025 [2] - The company's financial information service revenue rose by 27.5% to 1.5 billion, while cash received from sales of goods and services increased by 17% to 1.8 billion [2] - The company is focusing on marketing high-end software versions in Q1 and Q4, and mid-range products in Q2 and Q3 [2] Brokerage Segment - The brokerage business of the company saw a net income from commissions increase by 110% to 487 million, with client scale growing steadily [3] - Interest income rose by 33% to 101 million, and investment income increased by 12% to 160 million, primarily from proprietary trading [3] - The company’s underwriting and advisory services are progressing steadily, with asset management business also making good progress [3] Cost Structure - Overall expenses increased, but the expense ratio remained relatively stable; operating costs rose by 11% to 193 million [4] - Selling expenses increased by 38% to 1.1 billion, while the selling expense ratio decreased by 0.86 percentage points to 51.8% [4] - Management expenses rose by 44% to 650 million, driven by increased investments in business development and stock-based compensation [4] Financing Strategy - The company terminated its plan to issue A-shares to specific investors, which was initiated in 2022, due to comprehensive considerations of internal and external environments [5] - The company opted to issue subordinated bonds to supplement liquidity, raising a total of 480 million, with a 5-year term and a 5% interest rate [5] Profit Forecast and Investment Rating - The company is expected to continue investing in management expenses, with net profit forecasts for 2026-2028 adjusted to 264 million, 347 million, and 452 million respectively [6] - The company maintains a "buy" rating, anticipating continued growth and development in the brokerage sector [6]